159 related articles for article (PubMed ID: 38698862)
1. Prevalence and clinical markers of herpes simplex virus infection in oral lesions of bullous pemphigoid.
Zhang H; Yu M; Liang G; Li S; Zhao C; Jing K; Feng S
Front Immunol; 2024; 15():1387503. PubMed ID: 38698862
[TBL] [Abstract][Full Text] [Related]
2. Occult herpes simplex virus colonization of bullous dermatitides.
Nikkels AF; Delvenne P; Herfs M; Pierard GE
Am J Clin Dermatol; 2008; 9(3):163-8. PubMed ID: 18429645
[TBL] [Abstract][Full Text] [Related]
3. Features of oral, pharyngeal, and laryngeal lesions in bullous pemphigoid.
Ohki M; Kikuchi S; Ohata A; Baba Y; Ishikawa J; Sugimoto H
Ear Nose Throat J; 2016; 95(10-11):E1-E5. PubMed ID: 27792825
[TBL] [Abstract][Full Text] [Related]
4. Mucosal Involvement in Bullous Pemphigoid Is Mostly Associated with Disease Severity and to Absence of Anti-BP230 Autoantibody.
Clapé A; Muller C; Gatouillat G; Le Jan S; Barbe C; Pham BN; Antonicelli F; Bernard P
Front Immunol; 2018; 9():479. PubMed ID: 29662486
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the Prevalence of Mucosal Involvement in Bullous Pemphigoid.
Kridin K; Bergman R
JAMA Dermatol; 2019 Feb; 155(2):166-171. PubMed ID: 30624571
[TBL] [Abstract][Full Text] [Related]
6. Carriage of herpes simplex virus and human papillomavirus in oral mucosa is rare in young women: A long-term prospective follow-up.
Mäki J; Paavilainen H; Grénman S; Syrjänen S; Hukkanen V
J Clin Virol; 2015 Sep; 70():58-62. PubMed ID: 26305821
[TBL] [Abstract][Full Text] [Related]
7. Detection of herpes simplex virus in exacerbated pemphigus vulgaris by polymerase chain reaction.
Schlüpen EM; Wollenberg A; Hänel S; Stumpenhausen G; Volkenandt M
Dermatology; 1996; 192(4):312-6. PubMed ID: 8864363
[TBL] [Abstract][Full Text] [Related]
8. [The study of microbiota in patients with bullous lesions of the oral mucosa].
Rabinovich OF; Abramova ES; Umarova KV; Iskandaryan MA
Stomatologiia (Mosk); 2022; 101(3):18-21. PubMed ID: 35640174
[TBL] [Abstract][Full Text] [Related]
9. [Bullous autoimmune diseases of the oral mucosa].
Vaillant L
Rev Stomatol Chir Maxillofac; 1999 Oct; 100(5):230-9. PubMed ID: 10604215
[TBL] [Abstract][Full Text] [Related]
10. Survey of bullous pemphigoid disease in northern Iran.
Banihashemi M; Zabolinejad N; Vahabi S; Razavi HS
Int J Dermatol; 2015 Nov; 54(11):1246-9. PubMed ID: 25783773
[TBL] [Abstract][Full Text] [Related]
11. [Epidemiology, etiology and pathogenesis of oral mucosa bullous lesions].
Rabinovich OF; Rabinovich IM; Abramova ES
Stomatologiia (Mosk); 2019; 98(2):71-75. PubMed ID: 31089125
[TBL] [Abstract][Full Text] [Related]
12. Correlation of Serum Levels of IgE Autoantibodies Against BP180 With Bullous Pemphigoid Disease Activity.
van Beek N; Lüttmann N; Huebner F; Recke A; Karl I; Schulze FS; Zillikens D; Schmidt E
JAMA Dermatol; 2017 Jan; 153(1):30-38. PubMed ID: 27829102
[TBL] [Abstract][Full Text] [Related]
13. Herpes simplex virus infection and pemphigus.
Marzano AV; Tourlaki A; Merlo V; Spinelli D; Venegoni L; Crosti C
Int J Immunopathol Pharmacol; 2009; 22(3):781-6. PubMed ID: 19822095
[TBL] [Abstract][Full Text] [Related]
14. Basement membrane zone IgE deposition is associated with bullous pemphigoid disease severity and treatment results.
Kamata A; Kurihara Y; Funakoshi T; Takahashi H; Kuroda K; Hachiya T; Amagai M; Yamagami J
Br J Dermatol; 2020 May; 182(5):1221-1227. PubMed ID: 31330562
[TBL] [Abstract][Full Text] [Related]
15. A randomised controlled trial to compare the safety, effectiveness and cost-effectiveness of doxycycline (200 mg/day) with that of oral prednisolone (0.5 mg/kg/day) for initial treatment of bullous pemphigoid: the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) trial.
Chalmers JR; Wojnarowska F; Kirtschig G; Mason J; Childs M; Whitham D; Harman K; Chapman A; Walton S; Schmidt E; Godec TR; Nunn AJ; Williams HC
Health Technol Assess; 2017 Mar; 21(10):1-90. PubMed ID: 28406394
[TBL] [Abstract][Full Text] [Related]
16. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles.
Tanaka M; Hashimoto T; Dykes PJ; Nishikawa T
Clin Exp Dermatol; 1996 Jan; 21(1):23-7. PubMed ID: 8689764
[TBL] [Abstract][Full Text] [Related]
17. Non-Bullous Pemphigoid: A Single-Center Retrospective Study.
Moar A; Azzolini A; Tessari G; Schena D; Girolomoni G
Dermatology; 2021; 237(6):1039-1045. PubMed ID: 33979792
[TBL] [Abstract][Full Text] [Related]
18. Association of bullous pemphigoid and comorbid health conditions: a case-control study.
Lee S; Rastogi S; Hsu DY; Nardone B; Silverberg JI
Arch Dermatol Res; 2021 Jul; 313(5):327-332. PubMed ID: 32647978
[TBL] [Abstract][Full Text] [Related]
19. BPDAI and ABSIS correlate with serum anti-BP180 NC16A IgG but not with anti-BP230 IgG in patients with bullous pemphigoid.
Daneshpazhooh M; Ghiasi M; Lajevardi V; Nasiri N; Balighi K; Teimourpour A; Khosravi H; Saeidi V; Mahmoudi H; Chams-Davatchi C
Arch Dermatol Res; 2018 Apr; 310(3):255-259. PubMed ID: 29423547
[TBL] [Abstract][Full Text] [Related]
20. IgE anti-BP180 NC16A autoantibody in both serum and blister fluid samples does not correlate with disease activity of bullous pemphigoid.
Sun C; Qian H; Liang G; Xiang R; Zhao C; Li Z; Suo L; Jing K; Wang Y; Zhang H; Li X; Feng S
Eur J Dermatol; 2023 Dec; 33(6):595-603. PubMed ID: 38465539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
